Patent details

Basic Information

Publication number:

EP2363139

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101808574

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Method to increase class I presentation of exogenous antigens by human dendritic cells

French Title of Invention:

Procédé pour augmenter la présentation de classe I d'antigènes exogènes par cellules dendritiques humaines

German Title of Invention:

Verfahren zur Steigerung der Klasse I Darstellung von exogenen Antigenen durch humane dendritische Zellen

SPC Number:

Dates

Filing date:

11/05/2001

Grant date:

02/03/2016

EP Publication Date:

02/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/09/2011

EP B1 Publication Date:

02/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/05/2016

Expiration date:

11/05/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/05/2016

 

 

Name:

NorthWest Biotherapeutics Inc.

Address:

4800 Montgomery Lane, Suite 800, Bethesda, MD 20814, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

04/05/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Salgaller Michael L.

Address:

United States (US)

2

Name:

Boynton Alton L.

Address:

United States (US)

Priority

Priority Number:

203758 P

Priority Date:

12/05/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages